Endpoints News Dec 8, 2025 Dyne says Duchenne drug succeeds in pivotal study, heads to FDA for approval
FierceBiotech Dec 8, 2025 Dr. Reddy's pens $370M pact for rights to Immutep's phase 3-stage immunotherapy in certain markets
Endpoints News Dec 8, 2025 Cogent’s mastocytosis drug continues momentum, helps treat sicker patients
Endpoints News Dec 8, 2025 Day One was one of three parties interested in Mersana; Bihua Chen and Cormorant’s third SPAC
Endpoints News Dec 8, 2025 #ASH25: Kura, Syndax detail data for rival menin inhibitors as both eye earlier use in AML
BioPharma Dive Dec 8, 2025 Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar
Endpoints News Dec 8, 2025 Structure Therapeutics’ obesity pill stacks up with Novo and Lilly; Ascletis also reports early results
PLoS Biology Dec 8, 2025 Structures of G-protein coupled receptor HCAR3 in complex with selective agonists reveal the basis for ligand recognition and selectivity